EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improved hemodynamic performance and reduced paravalvular regurgitation with the SAPIEN 3 Ultra RESILIA valve: a propensity-matched single-center TAVR study

Meha Krishnareddigari, Golsa Joodi, Radoslav I Zinoviev, Suhas Yarra, Olcay Aksoy

Frontiers in Cardiovascular Medicine · 21.05.2026 · 13

DOI: 10.3389/fcvm.2026.1815034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 21.05.2026. Verfasst von Meha Krishnareddigari und 4 weiteren Autor:innen. Beteiligte Einrichtung: David Geffen School of Medicine, University of California, Los Angeles, CA, United States. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transcatheter aortic valve replacement (TAVR) has rapidly evolved into a standardized treatment for severe aortic stenosis, particularly in patients at increased surgical risk. The fifth-generation SAPIEN 3 Ultra RESILIA (S3UR) valve notably incorporates RESILIA-treated tissue as well as an enhanced external skirt in order to reduce structural valve deterioration (SVD) and paravalvular leak (PVL). However, real-world data on its clinical performance remains limited.

Objectives

To evaluate procedural, hemodynamic, and short-term clinical outcomes of the S3UR valve compared to earlier-generation SAPIEN 3 (S3) and SAPIEN 3 Ultra (S3U) platforms in Ronald Raegan UCLA medical center.

Methods

513 patients who underwent transfemoral TAVR at Ronald Reagan UCLA Medical Center between 2022 and 2024 were analyzed. Of these, 216 received the S3UR valve and 297 received S3U/S3 valves. Propensity-score matching (1:1) yielded 181 well-balanced patient pairs. Primary endpoints included device success per VARC-3 criteria, with secondary endpoints encompassing 30-day safety, echocardiographic performance, and procedural complications.

Results

The S3UR group demonstrated significantly lower post-procedural and 30-day mean aortic valve gradients (7.45 ± 3.37 mmHg and 9.06 ± 2.94 mmHg, respectively; p < 0.001) compared to the S3U/S3 group. Rates of moderate PVL were 0% in the S3UR group vs. 8.9–10.1% in S3U/S3 patients ( p < 0.001). Procedural success exceeded 98% in both groups, with no significant differences in stroke, mortality, or new pacemaker implantation. Readmission rates trended lower in the S3UR cohort (7.8% vs. 13.9%), though not statistically significant.

Conclusions

The SAPIEN 3 Ultra RESILIA valve demonstrated superior hemodynamic performance and significantly reduced PVL compared to earlier-generation balloon-expandable valves, while maintaining comparable safety and procedural success. These findings add institutional-level evidence to the growing body of data supporting the S3UR valve; however, multicenter prospective studies with longer follow-up are needed to confirm these results and assess long-term durability.

Schlagwörter

Stichwörter der Autor:innen

SAPIEN 3SAPIEN 3 UltraTAVR - outcomes and related issuesTAVR - transcatheter aortic valve replacementaortic valvesurgical outcome

Autor:innen und Institutionen

  • David Geffen School of Medicine, University of California, Los Angeles, CA, United States.
  • Yale School of Medicine, Yale University, New Haven, CT, United States.

Zitieren

APA

Krishnareddigari, M., Joodi, G., Zinoviev, R. I., Yarra, S., & Aksoy, O. (2026). Improved hemodynamic performance and reduced paravalvular regurgitation with the SAPIEN 3 Ultra RESILIA valve: a propensity-matched single-center TAVR study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1815034

Vancouver

Krishnareddigari M, Joodi G, Zinoviev RI, Yarra S, Aksoy O. Improved hemodynamic performance and reduced paravalvular regurgitation with the SAPIEN 3 Ultra RESILIA valve: a propensity-matched single-center TAVR study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1815034

BibTeX
@article{Krishnareddigari2026,
  author = {Krishnareddigari, Meha and Joodi, Golsa and Zinoviev, Radoslav I and Yarra, Suhas and Aksoy, Olcay},
  title = {Improved hemodynamic performance and reduced paravalvular regurgitation with the SAPIEN 3 Ultra RESILIA valve: a propensity-matched single-center TAVR study},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1815034}
}
Kostenlos starten →